Please login to the form below

Not currently logged in
Email:
Password:

behavioural economics

This page shows the latest behavioural economics news and features for those working in and with pharma, biotech and healthcare.

Behaviour change needs a quantified approach

Behaviour change needs a quantified approach

The great mysteries of human behaviour and its often irrational quirks are slowly but surely being solved, thanks to a combination of behavioural economics and booming research in neuroscience. ... Putting behaviour change into action. The pharmaceutical

Latest news

  • New philosophies driving transformative healthcare New philosophies driving transformative healthcare

    This changing approach is also reflected in national 'population level' projects, like Change4life in the UK, which often use behavioural economics techniques to nudge people into leading healthier lifestyles so

  • Drug of choice Drug of choice

    As the field of behavioural health economics continues to grow and gain influence over policy design, it should not escape us that the manner in which information is presented to patients

  • Things can only get better Things can only get better

    It's all about behaviours. Behavioural economics is gaining a lot of traction in the adherence space.

  • Changing behaviours begins at home Changing behaviours begins at home

    Behavioural economics is becoming a key ingredient in developing a sustainable brand strategy. ... Start at the end. Behavioural economics is therefore becoming a key ingredient in developing a sustainable brand strategy - and it's all part of an

  • Pharma must ‘create new social contract’ Pharma must ‘create new social contract’

    This body will call from experts in law, ethics, economics, behavioural science and other disciplines, to help: “Create a new framework for a social contract and clear research agenda” from the

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Nudge-nudge, think-think Nudge-nudge, think-think

    2002 Nobel Prize winner Daniel Kahneman described Loss Aversion as ‘the most significant contribution of psychology to behavioural economics.’ Moreover, when Richard Thaler, pioneer of the Nudge Theory, won the 2017 ... The best behavioural change

  • How behavioural design is transforming the role and impact of life sciences in healthcare How behavioural design is transforming the role and impact of life sciences in healthcare

    Behavioural economics will become essential to the future success of life sciences companies. ... While organisations are experimenting, we are yet to see healthcare accelerate the adoption of behavioural economics.

  • Indefinable, incomparable and enduring: the value of creativity Indefinable, incomparable and enduring: the value of creativity

    Firstly, there’s scope for creativity in how you understand your customers, leveraging behavioural economics or new data sources like the Internet of Things, wearables, sensors and social listening.

  • Stepping out Stepping out

    Securing behavioural change has become a global obsession that’s driving a step change in healthcare communications. ... The one-dimensional approach, says Fiona, has limitations. “There’s currently much focus on behavioural economics, which gives

  • If a nudge doesn’t last forever, how do we ensure sustained behaviour change? If a nudge doesn’t last forever, how do we ensure sustained behaviour change?

    Behavioural economics is an important behavioural science that helps to explain our behaviour. ... Its importance in our current way of thinking and understanding human behaviour has been recognised in the award of Nobel prizes to two eminent behavioural

More from intelligence
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics